Welcome to the e-CCO Library!

P066 Azathioprine linked with impaired intestinal epithelial regeneration in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Borycka-Kiciak1, A. Pietrzak2,3, K. Ferenc4, P. Pietrzak4,5, L. Janaszek1, W. Tarnowski1, R. Zabielski4

Created: Thursday, 30 January 2020, 10:12 AM
P066: CCR2-monocytes are essential for the resolution of inflammation and tissue repair in colitis.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Stakenborg, G. Goverse, G. Farro, P. J. Gomez-Pinilla, 
G. E. Boeckxstaens, G. Matteoli*

Created: Friday, 22 February 2019, 9:49 AM
P066: Exploration of critical molecules for optimizing treatment by analyzing inflammatory cytokines in the intestinal mucosa of patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Yokoyama, Y.(1);Yamakawa, T.(1);Hayashi, Y.(1);Kazama, T.(1);Hirayama, D.(1);Nakase, H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P066: Fibrostenotic phenotype of fibroblasts in Crohn's disease is dependent on tissue stiffness and reversed by LOX inhibition
Year: 2017
Source: ECCO '17 Barcelona
Authors:

de Bruyn J.*1, van den Brink G.1, Steenkamer J.1, Buskens C.2, Bemelman W.2, Meisner S.3, Muncan V.3, te Velde A.3, D'Haens G.4, Wildenberg M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P066: Lower serum concentration of sulfated bile acids is associated with Primary Sclerosing Cholangitis Inflammatory Bowel Disease comorbidity and advanced liver fibrosis
Year: 2022
Source: ECCO'22
Authors: Leibovitzh, H.(1);Nayeri, S.(2);Borowski, K.(2);Hernandez-Rocha, C.(1);Lee, S.H.(1);Turpin, W.(1);Stempak, J.(2);Sandhu, I.(2);Milgrom, R.(2);Smith, M.I.(2);Croitoru, K.(1);Hirschfield, G.M.(3);Gulamhusein, A.(3);Silverberg, M.S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P066: ON104, a novel bioengineered antibody targeting oxidized Macrophage Migration Inhibitory Factor (oxMIF) shows efficacy in two distinct models of experimental colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ferhat, M.(1)*;Mangano, K.(2);Nicoletti, F.(2);Landlinger, C.(1);Michael, T.(1);
Created: Friday, 14 July 2023, 10:48 AM
P066: Pharmacologic inhibition of integrin αvβ6 causes tumour shrinkage in colitis associated mouse colon tumours
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Busenhart*, L. Hering, K. Atrott, E. Patsenker, F. Stickel, K. Bäbler, B. Weder, A. Wyss, G. Rogler, M. Spalinger, M. Scharl

Created: Thursday, 21 February 2019, 9:14 AM
P066: Validation of assay for detection of free soluble mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in human serum and cerebrospinal fluid
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Fernandez Ocana1, J. Y. Zhang2, B. R. Jones3, S. W. Martin2, M. Goetsch*4, H. Neubert1

Created: Friday, 22 February 2019, 9:41 AM
P067 Proteins citrullination and Crohn’s disease: PAD4 but not PAD2 is a strong marker of ileal inflammation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Dragoni1,2, B. Creyns2,3, G. De Hertogh4, B. Verstockt2,5, W.J. Wollants2, B.J. Ke2, L. Marcellis4, G. Matteoli2, A. D’Hoore6, A. Galli1, M. Ferrante2,5, S. Vermeire2,5

Created: Thursday, 30 January 2020, 10:12 AM
P067: Angiogenic characterisation of Crohn’s disease mesenteric adipose tissue
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Eddama*1, R. Cohen1, M. Rodriguez-Justo2, I. Evans3, L. Shen4, L. Clapp4, M. Loizidou5

Created: Friday, 22 February 2019, 9:49 AM
P067: Fractal analysis of extracellular matrix as a new histological method for observer-independent quantification of intestinal fibrosis in Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Weber, M.C.(1)*;Schmidt, K.(1);Buck, A.(1);Kasajima, A.(2);Becker, S.(3);Wilhelm, D.(1);Friess, H.(4);Neumann, P.A.(1);
Created: Friday, 14 July 2023, 10:48 AM
P067: Human colonic subepithelial myofibroblasts from IBD patients demonstrate a differential expression of Th-related cytokine receptors compared with healthy controls
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Bamias4, E. Filidou1, V. Valatas2, I. Drygiannakis2, K. Arvanitidis1, S. Vradelis3, G. Kouklakis*3, G. Kolios1

Created: Friday, 22 February 2019, 9:41 AM
P067: Human intestinal CD103+SIRPα+ conventional dendritic cells from patients with Crohn´s disease prime IL-17+ T-cells.
Year: 2022
Source: ECCO'22
Authors: Bernardo, D.(1,2);Arribas-Rodriguez, E.(1);De Castro, C.G.(1);Fiz-Lopez, A.(1);De Prado, A.(1,3);Fernandez-Salazar, L.(4);Barrio, J.(3);Izquierdo, S.(4);Garcia-Alonso, J.(3);De Andres, B.(5);Garcia-Abril, J.M.(6);Romero, A.(5);Sanchez-Gonzalez, J.(6);Garrote, J.A.(1);Arranz, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P067: Molecular profiling of early Crohn's disease reveals a prominent role for WNT5A
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Verstockt S.*1, Van der Goten J.2, Vancamelbeke M.2, Verstockt B.2, Van Lommel L.3, Schuit F.3, Rutgeerts P.2, Ferrante M.2, Vermeire S.2, Arijs I.2,4,5, Cleynen I.1

Created: Wednesday, 20 February 2019, 10:36 AM
P067: Proliferating intestinal macrophage populations in human inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. McDonald1*, P. Wright1, C. Bain2, A. Bravo-Blas1, E. Robertson3,4, A. Mowat1, S. Milling1, D. Gaya4

Created: Thursday, 21 February 2019, 9:14 AM
P067: The effect of a probiotic mix on mucosal healing and fibrotic responses in healthy colonic subepithelial myofibroblasts.
Year: 2021
Source: ECCO'21 Virtual
Authors: Tarapatzi, G.(1);Filidou, E.(1);Kandilogiannakis, L.(1);Arvanitidis, K.(1);Vradelis, S.(2);Kotzampassi, K.(3);Kolios, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P068 Erythrocyte and reticulocyte parameters in children with inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Semikina1, A. Potapov2, V. Tsvetkova2, A. Anoushenko2, S. Akulova1

Created: Thursday, 30 January 2020, 10:12 AM
P068: Aberrant brain function in active-stage ulcerative colitis patients: a resting-state functional MRI study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Fan*1, S. Zhang1, J. Hu1, B. Liu1, L. Wen1, M. Gong1, G. Wang1, L. Yang2, Y. Chen2, H. Chen2, H. Guo2, D. Zhang1

Created: Friday, 22 February 2019, 9:41 AM
P068: Anti-fibrotic therapy for Crohn’s disease: in-vitro proof of concept with a selective ROCK2 inhibitor, LYC-53976, in the treatment of human intestinal myofibroblasts in stiffness and transforming growth factor β models
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Rodansky1, X. Liu2, L. A. Johnson1, K. Demock2, A. J. Celeste2, L. L. Carter2, P. D. R. Higgins*1

Created: Friday, 22 February 2019, 9:49 AM
P068: Discovery of IBD3540: A Novel Gut-Restricted Glutamate Carboxypeptidase II Inhibitor with Preclinical Anti-Colitis Activity
Year: 2022
Source: ECCO'22
Authors: Peters, D.(1);Norris, L.(2);Tenora, L.(3);Snajdr, I.(3);Zhu, X.(4);Sakamoto, S.(4);Veeravalli, V.(2);Thomas, A.(2);Majer, P.(3);Rais, R.(2);Slusher, B.(2);
Created: Friday, 11 February 2022, 3:52 PM